InvestorsHub Logo
Followers 241
Posts 12183
Boards Moderated 0
Alias Born 08/14/2003

Re: flipper44 post# 254873

Monday, 12/09/2019 1:58:53 PM

Monday, December 09, 2019 1:58:53 PM

Post# of 693693
Flipper,

I certainly hope you're right, but sustaining a $5 billion market cap, so as to attract an even bigger buyout price, isn't something I've previously observed prior to FDA approval in other companies. A few billion, yes, even more with a partnership, but I believe $5 billion or more with neither partnership or FDA approval is certainly a reasonable high, but I find it hard to believe it will be sustained. It could easily be exceeded with either a partnership, or regulatory approval anywhere, as both would begin to initiate substantial funding and earnings.

I really cannot say if regulators other than the FDA can act dramatically faster, but I'd be very surprised to see FDA action before the end of next year, at the earliest, if a BLA is filed by mid year.

I don't believe a buyout can be a large multiple of an emotional high, but it can be at a sustained high. If a price of $5 is sustained, a $15 buyout could be reasonable, just a little more than that and you have $20, but that's the extreme. Most buyouts aren't more than double the current price, and many are less than 50% above the current price.

It's my belief that a company looking to acquire another company where the price is agreed on will help boost the stock price toward that price to not be viewed as overpaying for what they purchased. A BP would be chastised by its shareholders if it bid 5 times what a company was selling for, but if that company rose to half the offering price in a matter of days or weeks before the offer, it would be no problem. I still believe more about Direct is needed to bring numbers like $20 billion, but that could be possible in a year or so.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News